Share

May 22, 2012; 78 (21) Articles

Comparative safety of antiepileptic drugs during pregnancy

S. Hernández-Díaz, C.R. Smith, A. Shen, R. Mittendorf, W.A. Hauser, M. Yerby, L.B. Holmes, For the North American AED Pregnancy Registry
First published May 2, 2012, DOI: https://doi.org/10.1212/WNL.0b013e3182574f39
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
2816

Share

Article Information

vol. 78 no. 21 1692-1699
DOI: 
https://doi.org/10.1212/WNL.0b013e3182574f39
PubMed: 
22551726
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received August 30, 2011
  • Accepted January 25, 2012
  • First Published May 2, 2012.

Article Versions

Copyright & Usage: 
Copyright © 2012 by AAN Enterprises, Inc.

Author Disclosures

    1. S. Hernández-Díaz, MD, DrPH,
    2. C.R. Smith, MPH,
    3. A. Shen, MPH,
    4. R. Mittendorf, MD, DrPH,
    5. W.A. Hauser, MD,
    6. M. Yerby, MD,
    7. L.B. Holmes, MD and
    8. For the North American AED Pregnancy Registry
  1. S. Hernández-Díaz, MD, DrPH,
    2. Scientific Advisory Boards:

    1. Served as scientific advisory board for Novartis and GSK Pregnancy Registries.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Consultant for Data safety monitory board for Novartis.

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Salary support (2.5-5%) from funds provided by sponsors of the North American AED Pregnancy Registry: Abbott, Eisai, Novartis, Ortho-McNeil, Pfizer and Sunovion Pharmaceuticals.

    Research Support, Government Entities:

    1. NIH R01 HD046595-01A1. (MPI: Hernández-Díaz) Teratogenicity of Drugs Commonly Used in Pregnancy. National Institute of Child and Human Development. 2005- 2013 NIH R01 HD056940-01A2. (MPI: Hernández-Díaz) Assessment of Infant Outcomes after in utero Exposure to Antiretroviral Therapy. 2009-2012. NIH R01 HD059861-01A1 National Institute of Environmental Health Sciences. (MPI: Hernández-Díaz) Phthalates in Medications and the Risk of Male Genital Malformations. 2009-2013. AHRQ (MPI: Hernández-Díaz) Anti-Depressants during Pregnancy Postpartum: Safety and Effectiveness. 2009-2014. NIH U01 HD52104-01. NICHD.(PI: Van Dyke) Pediatric HIV/AIDS Cohort Study (PHACS) – Coordination Center. 2005- 2011.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. C.R. Smith, MPH,
    3. Scientific Advisory Boards:

    1. 1) National Pregnancy Registry for Atypical Antipsychotics

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. 1) Abbott 2) Eisai 3) Novartis 4) Ortho-McNeil 5) Pfizer 6) Sunovion 7) Aurobindo 8) Dr Reddy’s Lab 9) GSK 10) Sanoz 11) Teva

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. A. Shen, MPH,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Received financial assistance from Tufts University (while a MPH student) to attend and present at the 2010 American Public Health Association annual meeting.

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. 1) Abbott 2) Eisai 3) Novartis 4) Ortho-McNeil 5) Pfizer 6) Sunovion 7) Aurobindo 8) Dr Reddy’s Labs 9) GSK 10) Sandoz 11) Teva

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. R. Mittendorf, MD, DrPH,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Current Health Reviews for Women, 2002-2011

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. Australian Research Centre for Health of Women and Babies, Adelaide, SA. AMICABLE (Antenatal Magnesium IPD International Collaboration: Assessing the Benefits for Babies using the Best Level of Evidence). Co-Principal Investigator.

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. W.A. Hauser, MD,
    6. Scientific Advisory Boards:

    1. DSMB NINDS neurocysticercosis treatment King Pharma Pharma diazepam injector DSMB Cephalon

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Editorial board Acta Neurologica Scandinavia 2000 present Editorial board Neuroepidemiology 2005 present Editorial board Epilepsy Research 2000 present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. 1. Pfizer, Consultant, 2010 2. Neuropace Consultant 2011

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Developmental disabilities in Children with epilepsy PI David Lindenbaum, University of Kansas, Lawrence. Consultant CDC 2008-2011 INCIDENCE AND PROGNOSIS OF EPILEPSY IN HARLEM, NY: CDC PI: Dale Hesdorffer Grant #: 1 U48 DP001916-01 coinvestigator S109/30/09 - 09/29/14 FAA consultant neurologist

    Research Support, Academic Entities:

    1. Mayo Clinic, Senior Visiting Scientist, 1984 present

    Research Support, Foundations and Societies:

    1. Hotchkiss Neurological Institute, external reviewer 2008- 2010

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. FAA Consultant

  6. M. Yerby, MD,
    7. Scientific Advisory Boards:

    1. North American AED and Pregnancy Registry - Non Profit entity Speakers’ Bureaus: Lundbeck Speaker’s bureau UCB Speaker’s bureau

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Clinical trial support from Vanquix, and UCB

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. L.B. Holmes, MD and
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Abbott, Eisai, Novartis, Ortho McNeil, Pfizer and Sunovion

    Research Support, Government Entities:

    1. Supported, in part, by a subcontract from the Center for Birth Defects Research and Prevention in the Massachusetts Department of Public Health, Boston, MA

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. For the North American AED Pregnancy Registry
    1. North American AED (Antiepileptic Drug) Pregnancy RegistryScientific Advisory Committee
  9. North American AED (Antiepileptic Drug) Pregnancy RegistryScientific Advisory Committee
    1. North American AED Pregnancy Registry
  10. North American AED Pregnancy Registry
  1. From the Department of Epidemiology (S.H.-D., C.R.S.), Harvard School of Public Health, Boston, MA; North American AED Pregnancy Registry (A.S., L.B.H.), MassGeneral Hospital for Children, Boston, MA; Loyola University Health System (R.M.), Chicago, IL; College of Physicians and Surgeons and Mailman School of Public Health (W.A.H.), Columbia University, New York, NY; and Oregon Health and Science University (M.Y.), Portland, OR.
  1. Correspondence & reprint requests to Dr. Hernández-Díaz: shernan{at}hsph.harvard.edu
View Full Text

Article usage

Article usage: May 2012 to April 2023

AbstractFullPdfSource
May 20122664112297Highwire
Jun 2012933106177Highwire
Jul 201264993128Highwire
Aug 20123496371Highwire
Sep 20123975385Highwire
Oct 20123474254Highwire
Nov 20123185165Highwire
Dec 20122543840Highwire
Jan 20133342543Highwire
Feb 20133354859Highwire
Mar 20132974147Highwire
Apr 20133674243Highwire
May 20133504053Highwire
Jun 20132251833Highwire
Jul 20132783548Highwire
Aug 20132271719Highwire
Sep 20132713338Highwire
Oct 20133622836Highwire
Nov 20133663731Highwire
Dec 20132162426Highwire
Jan 20143372837Highwire
Feb 20142323041Highwire
Mar 20142101934Highwire
Apr 20142443636Highwire
May 20143492632Highwire
Jun 20142442726Highwire
Jul 20142102324Highwire
Aug 20142001825Highwire
Sep 20142102326Highwire
Oct 20142071618Highwire
Nov 20142392322Highwire
Dec 20141551215Highwire
Jan 20151681719Highwire
Feb 20151821112Highwire
Mar 20152792422Highwire
Apr 20152051324Highwire
May 20151732022Highwire
Jun 20151562426Highwire
Jul 20151741419Highwire
Aug 20151781413Highwire
Sep 20152182427Highwire
Oct 20152152223Highwire
Nov 20152141721Highwire
Dec 20152402325Highwire
Jan 20162141111Highwire
Feb 20162711524Highwire
Mar 20163251620Highwire
Apr 2016289618Highwire
May 20163293826Highwire
Jun 20162991610Highwire
Jul 20162611010Highwire
Aug 20163342326Highwire
Sep 20162631319Highwire
Oct 20164141313Highwire
Nov 20162721319Highwire
Dec 2016194104Highwire
Jan 20172701313Highwire
Feb 20173211010Highwire
Mar 20173361216Highwire
Apr 20173721110Highwire
May 20174732317Highwire
Jun 201737739Highwire
Jul 201744127Highwire
Aug 2017448814Highwire
Sep 20175195419Highwire
Oct 20177774619Highwire
Nov 20177914010Highwire
Dec 2017515154Highwire
Jan 20185112012Highwire
Feb 2018473158Highwire
Mar 2018588157Highwire
Apr 20185481812Highwire
May 20185683019Highwire
Jun 2018565178Highwire
Jul 2018383106Highwire
Aug 20183142412Highwire
Sep 2018353218Highwire
Oct 2018386158Highwire
Nov 2018313148Highwire
Dec 2018256218Highwire
Jan 20192942210Highwire
Feb 2019280138Highwire
Mar 20193311610Highwire
Apr 20193111711Highwire
May 20192822810Highwire
Jun 20192541712Highwire
Jul 2019279162Highwire
Aug 201916395Highwire
Sep 20192831619Highwire
Oct 20192871911Highwire
Nov 2019236189Highwire
Dec 201919677Highwire
Jan 202022774Highwire
Feb 2020258163Highwire
Mar 2020244166Highwire
Apr 202022655Highwire
May 2020361143Highwire
Jun 202014642Highwire
Jul 2020162188Highwire
Aug 202013668Highwire
Sep 20202263013Highwire
Oct 2020180106Highwire
Nov 2020191710Highwire
Dec 2020183107Highwire
Jan 202116795Highwire
Feb 2021152214Highwire
Mar 20212022111Highwire
Apr 2021203135Highwire
May 2021146329Highwire
Jun 2021175112Highwire
Jul 2021125205Highwire
Aug 2021184166Highwire
Sep 2021172185Highwire
Oct 2021212123Highwire
Nov 202118671Highwire
Dec 2021169149Highwire
Jan 202218394Highwire
Feb 2022189106Highwire
Mar 20221991411Highwire
Apr 202216088Highwire
May 20221832113Highwire
Jun 2022188116Highwire
Jul 2022105169Highwire
Aug 2022153116Highwire
Sep 2022167126Highwire
Oct 2022230188Highwire
Nov 2022201116Highwire
Dec 202214938Highwire
Jan 202322364Highwire
Feb 202319064Highwire
Mar 2023181106Highwire
Apr 20231491311Highwire

Cited By...

Letters: Rapid online correspondence

  • Response to Maheshwari et al.
    • Sonia Hernandez-Diaz, Associate Professor, Harvard School of Public Health
    • Lewis B. Holmes, Boston, MA, USA
    Submitted September 07, 2012
  • Are newer antiepileptics really safer?
    • Amit Maheshwari, senior resident neurology, SAIMS Indore India
    • Amit Maheshwari,Sunil Athale,O.P.Lekhra,Kapil Telang-all Indore India
    Submitted August 28, 2012
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top

More Online

CME Course

Topics Discussed

Alert Me

Recommended articles